100
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Prognostic Significance of Uric Acid in Patients with Obstructive and Nonobstructive Coronary Artery Disease Undergoing D-SPECT

, , , , , , ORCID Icon, & show all
Pages 1955-1965 | Published online: 16 Nov 2021

Figures & data

Table 1 Baseline Characteristics of Study Cohort by Serum Uric Acid

Table 2 Risk of Cardiovascular Events by SUA Levels

Figure 1 Long-term risk of MACE in the whole cohort (A) PSM cohort (B) obstructive CAD cohort (C) and nonobstructive CAD cohort (D) according to the SUA levels.

Abbreviations: CAD, coronary artery disease; MACE, major adverse cardiovascular events; PSM, propensity-score matching; SUA, serum uric acid.
Figure 1 Long-term risk of MACE in the whole cohort (A) PSM cohort (B) obstructive CAD cohort (C) and nonobstructive CAD cohort (D) according to the SUA levels.

Figure 2 The trajectories of SUA levels with MACE in the whole cohort (A) obstructive CAD cohort (B) nonobstructive CAD cohort (C) and low-, intermediate-, and high-risk cohorts stratified by HEART score (D–F) The solid line in each figure indicates the HR, and the dashed lines indicate the 95% CIs. The Orange reference line indicates an HR of 1.00. The median value of SUA levels (5.6 mg/dL) was treated as the reference. Other abbreviations referred to .

Abbreviations: CI, confidence interval; HR, hazard ratio.
Figure 2 The trajectories of SUA levels with MACE in the whole cohort (A) obstructive CAD cohort (B) nonobstructive CAD cohort (C) and low-, intermediate-, and high-risk cohorts stratified by HEART score (D–F) The solid line in each figure indicates the HR, and the dashed lines indicate the 95% CIs. The Orange reference line indicates an HR of 1.00. The median value of SUA levels (5.6 mg/dL) was treated as the reference. Other abbreviations referred to Figure 1.

Figure 3 Subgroup analyses based on MPI characteristics in the whole cohort (A) obstructive CAD cohort (B) and nonobstructive CAD cohort (C) The risks were demonstrated as HRs and 95% CIs after adjustment for the HEART score.

Abbreviations: MPI, myocardial perfusion imaging; SDS, summed difference score; SRS, summed rest score; SSS, summed stress score; TID, transient ischemic dilation; TPD, total perfusion defects.
Figure 3 Subgroup analyses based on MPI characteristics in the whole cohort (A) obstructive CAD cohort (B) and nonobstructive CAD cohort (C) The risks were demonstrated as HRs and 95% CIs after adjustment for the HEART score.